News

A new HealthMine survey sheds light on how payers can better connect Medicare members to their health plan.

Pharma maker pleads guilty that one of its major drugs was misbranded in a federal court case brought by FDA and the US Department of Justice.

FDA approved the first generic version of oseltamivir phosphate (Tamiflu, Roche) for oral suspension to treat influenza A and B, plus 2 other noteworthy therapies.

FDA is advising that these 2 opioid addiction medications should not be withheld from patients taking benzodiazepines or other drugs that depress the central nervous system.

A survey from HealthScape Advisors and the Health Plan Alliance has revealing findings about value-based payment models.

Payers must reinvent efforts to reduce cancer cost and increase quality for a value-based care world. Here’s five rules to follow.

Here are the top 10 states with the highest uninsured rate, according to personal-finance website WalletHub.

A poll by Morning Consult on behalf of University of Phoenix, has revealing results about online health resources.

While FDA has approved a handful of biosimilar drugs, the agency just approved the first biosimilar that treats a variety of types of cancer.

Universal healthcare is top of mind for healthcare stakeholders. Here’s four things you need to know about it right now.

A survey of nearly 200 healthcare executives has interesting findings related to population health management.

A new study from The Ohio State University reveals eye-opening findings about individuals with developmental disabilities.

A new Commonwealth Fund has surprising findings following ACA’s major coverage expansions.

A new report from West has surprising findings about high-deductible health plans and insurance coverage.

Here are 5 things to know about GPOs, their business model and role in the supply chain, and their impact on healthcare costs and competition

Experts weigh in on the top population health management changes managed care executives should be watching.

Even before Hurricane Harvey made landfall in Texas, health insurers were prepared for the worst. Here, they discuss what steps they took before the storm hit.

A study from Humana and the CDC sheds eye-opening results about arthritis and health-related quality of life.

FDA warned about an injunction or seizure if Meridian Medical Technologies, a division of Pfizer, does not correct its problems with the EpiPen (epinephrine auto-injector).

An increased risk of deaths for patients in clinical trials receiving this cancer drug and two other drugs led FDA to stop the clinical trials.

Technology is enabling healthcare consumers the freedom to choose. With increasing choices, convenience is at the forefront of the next evolution of healthcare, and companies need to focus on delivering great end-to-end experiences to meet the needs of today’s consumers.

What technology will have the biggest impact on your managed care organization? Healthcare executives weigh in.

Millennials are tomorrow’s leaders, and they bring a lot to the table. Here are some benefits they bring to managed care organizations.

Clinical experience and business acumen are important factors in a successful healthcare leader, but the ability to accept change and help an organization adapt are perhaps the most critical.

This new hospital model offers an opportunity to attract new patients in an efficient, cost-effective setting.

CMS’ Quality Payment Program launched in 2016 as part of MACRA. Here’s what’s in store for Year 2.

PBMs partnering with pharmacies and drug makers may have a solution to nonadherence due to high pharma costs.

The first therapy based on gene transfer has been approved by the FDA. What’s next for healthcare executives?